TANESPIMYCIN Gene Set

Dataset DGIdb Drug Targets 2026
Category physical interactions
Type drug
Description A 19-membered macrocyle comprising geldanamycin with its 17-methoxy substituent replaced by an allylamino group. It is a potent inhibitor of heat shock protein 90 (Hsp90). A less toxic analogue than geldanamycin, it induces apoptosis and displays antitumor effects. (Chemical Entities of Biological Interest Ontology, CHEBI_64153)
External Link https://dgidb.org/results?searchType=drug&searchTerms=TANESPIMYCIN
Similar Terms
Downloads & Tools

Genes

12 interacting proteins for the TANESPIMYCIN drug from theDGIdb Drug Targets 2026 dataset.

Symbol Name Standardized Value
HSP90AB1 heat shock protein 90kDa alpha (cytosolic), class B member 1 1.62037
XIAP X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase 0.326741
CDK4 cyclin-dependent kinase 4 0.165671
HSP90AA1 heat shock protein 90kDa alpha (cytosolic), class A member 1 0.154772
HIF1A hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) 0.119216
RET ret proto-oncogene 0.11532
JAK2 Janus kinase 2 0.07306
MTOR mechanistic target of rapamycin (serine/threonine kinase) 0.0498418
PIK3CA phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha 0.0417116
TP53 tumor protein p53 0.0383565
GMNN geminin, DNA replication inhibitor 0.0183029
AR androgen receptor 0.00994588